CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54
Subscribe

Eribulin

Product Description

Breast cancer liposarcoma
Status: under development

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

Country/Region:

China
On CPHI since:

2021
Certificates:

2

Company types

Academic/Research

Manufacturer/Innovator

Compare Add to favorites Added to favorites

Specifications

CAS Registry Number

253128-41-5

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

Country/Region:

China
On CPHI since:

2021
Certificates:

2

Company types

Academic/Research

Manufacturer/Innovator

Compare Add to favorites Added to favorites

More Products from ZENJI PHARMACEUTICALS (SU ZHOU) LTD. (2)

Product Clopidogrel Bisulfate

Antiplatelet agent

Compare
Product Molnupiravir

COVID-19Status: DMF available

Compare

CPHI Online is the largest global marketplace in the pharma ingredients industry

Eribulin

Product Description

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

Specifications

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

More Products from ZENJI PHARMACEUTICALS (SU ZHOU) LTD. (2)

Product Clopidogrel Bisulfate

Product Molnupiravir

Coming soon

ZENJI PHARMACEUTICALS (SU ZHOU) LTD.

Address

Telephone

Website

Send a message to

Request for general information

Send a message to